1. Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

   Banerji, U., van Herpen, C. M. L., Saura, C., Thistiethwaite, F., Lord, S., Moreno, V., Macpherson, I. R., Boni, V., Rolfo, C., de Vries, E. G. E., Rottey, S., Geenen, J., Eskens, F., Gil-Martin, M., Mommers, E. C., Koper, N. P. & Aftimos, P., Aug-2019, In : Lancet Oncology. 20, 8, p. 1124-1135 12 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

   CheckMate 214 investigators, Motzer, R. J., Rini, B. I., McDermott, D. F., Arén Frontera, O., Hammers, H. J., Carducci, M. A., Salman, P., Escudier, B., Beuselinck, B., Amin, A., Porta, C., George, S., Neiman, V., Bracarda, S., Tykodi, S. S., Barthélémy, P., Leibowitz-Amit, R., Plimack, E. R., Oosting, S. F., Redman, B., Melichar, B., Powles, T., Nathan, P., Oudard, S., Pook, D., Choueiri, T. K., Donskov, F., Grimm, M-O., Gurney, H., Heng, D. Y. C., Kollmannsberger, C. K., Harrison, M. R., Tomita, Y., Duran, I., Grünwald, V., McHenry, M. B., Mekan, S. & Tannir, N. M., 16-Aug-2019, In : Lancet Oncology. 16 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

   PORTEC study group, de Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P. B., Ledermann, J. A., Khaw, P., D'Amico, R., Fyles, A., Baron, M-H., Jürgenliemk-Schulz, I. M., Kitchener, H. C., Nijman, H. W., Wilson, G., Brooks, S., Gribaudo, S., Provencher, D., Hanzen, C., Kruitwagen, R. F., Smit, V. T. H. B. M., Singh, N., Do, V., Lissoni, A., Nout, R. A., Feeney, A., Verhoeven-Adema, K. W., Putter, H. & Creutzberg, C. L., 22-Jul-2019, In : Lancet Oncology. 13 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder

   Gómez García, E. B. & Knoers, N. V. A. M., Jul-2009, In : Lancet Oncology. 10, 7, p. 727-35 9 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

5. Use of the Child-Pugh score in anticancer drug dosing decision making: proceed with caution - Authors' reply

   Krens, S. D., Lassche, G., Jansman, F. G. A., Desar, I. M. E., Lankheet, N. A. G., Burger, D. M., van Herpen, C. M. L. & van Erp, N. P., Jun-2019, In : Lancet Oncology. 20, 6, 1 p., e290.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (72) »